Data from this new study suggest melanoma cases rose at a slower rate in lower-income countries, but the authors say that may be due to differences in case documentation.
Archive | Melanoma News
Melanoma Prevalence, Mortality Mostly Stable Over the Past 30 Years
Posted in Melanoma News, Health Professionals, Of Interest
Patients present with later stage melanoma during COVID-19 pandemic
Many melanoma patients presented with more advanced disease during the COVID-19 pandemic, according to a small study published in the Journal of the American Academy of Dermatology.
Posted in Melanoma News, Health Professionals, Of Interest
Sotigalimab Plus Nivolumab Shows Encouraging Activity in Anti–PD-1 Refractory Melanoma
The combination of sotigalimab (APX005M) and nivolumab (Opdivo) elicited durable responses with a reasonable safety profile in patients with melanoma who were refractory to anti–PD-1 therapy, according to data from a phase 2 trial (NCT03123783).
Posted in Melanoma News, Health Professionals, Clinical Trials
What’s Ahead for Melanoma Management
Immunotherapy, intralesional treatments, multidisciplinary care teams define rapidly-evolving multimodal approach.
Posted in Melanoma News, Health Professionals, Of Interest
 |
 |
 |
 |
